The executive body of the European Union (EU) would seek to launch a legal process against the vaccime producer company for problems with the supply of vaccines to this region, EU sources pointed out.
The possibility of a lawsuit against AstraZeneca was among the issues discussed yesterday by diplomats from five countries, according to Politico publication, quoted by the capital’s press.
The purpose of such a decision would be aimed at pressuring AstraZeneca to comply with its commitments with the EU, which must receive almost one billion doses from AstraZeneca, Pfizer/BioNTech, Moderna and Johnson and Johnson in 2021.
The meeting came shortly before this week’s deadline for the Swedish-British consortium to supply the agreed volumes of vaccine and set a deadline for the start of claims.
In the first quarter of 2021, AstraZeneca delivered 70 million doses of 100 million contracted with the community bloc, and in the second quarter it announced commitments of only 70 million, when the contract spoke of 300 million bulbs.
To this must be added the boycott by some 12 EU States for the use of AstraZeneca’s immunizer, after deaths and several cases of thrombi in patients, the formation of which could have been caused by the aforementioned vaccine.